Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8454)
All Articles published online
|
Publishing Process of This Article
|
Feb 27, 2018 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | She WH, Chan ACY, Cheung TT, Lo CM, Chok KSH. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels. World J Hepatol 2018; 10(2): 308-318 [PMID: 29527266 DOI: 10.4254/wjh.v10.i2.308] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i2/308.htm |
| Number | Citing Articles |
| 1 |
Thorvardur R. Halfdanarson, Mohamed Bassam Sonbol, Jason S. Starr. Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease. 2023; : 358 doi: 10.1016/B978-0-323-68135-3.00051-9
|
| 2 |
Tsuyoshi Shimamura, Ryoichi Goto, Masaaki Watanabe, Norio Kawamura, Yasutsugu Takada. Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?. Cancers 2022; 14(2): 419 doi: 10.3390/cancers14020419
|
| 3 |
Shaakir Hasan, Stephen Abel, Tadahiro Uemura, Vivek Verma, Eugene J. Koay, Joseph Herman, Ngoc Thai, Alexander Kirichenko. Liver transplant mortality and morbidity following preoperative radiotherapy for hepatocellular carcinoma. HPB 2020; 22(5): 770 doi: 10.1016/j.hpb.2019.10.006
|
| 4 |
A. V. Moiseenko, A. A. Polikarpov, D. A. Granov, P. G. Tarazov, C. V. Shapoval, A. R. Sheraliev, A. G. Karahanova. The possibilities of interventional radiology before and after orthotopic liver transplantation. Russian Journal of Transplantology and Artificial Organs 2018; 20(3): 75 doi: 10.15825/1995-1191-2018-3-75-79
|
| 5 |
Bo Hu, Xiao-Bo Yang, Xin-Ting Sang. Liver graft rejection following immune checkpoint inhibitors treatment: a review. Medical Oncology 2019; 36(11) doi: 10.1007/s12032-019-1316-7
|
| 6 |
Diamantis I. Tsilimigras, Fabio Bagante, Dimitrios Moris, Katiuscha Merath, Anghela Z. Paredes, Kota Sahara, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients. Surgery 2019; 166(6): 967 doi: 10.1016/j.surg.2019.08.010
|
| 7 |
Alexander H. Shannon, Samantha M. Ruff, Austin D. Schenk, Kenneth Washburn, Timothy M. Pawlik. Updates and Expert Opinions on Liver Transplantation for Gastrointestinal Malignancies. Medicina 2023; 59(7): 1290 doi: 10.3390/medicina59071290
|
| 8 |
Sai Zhao, Zhi-Chao Liu, Yong-Xia Zhao, Tian-Le Zhang, Zi-Wei Zuo. A feasibility study of different GSI noise indexes and concentrations of contrast medium in hepatic CT angiography of overweight patients: image quality, radiation dose, and iodine intake. Japanese Journal of Radiology 2023; 41(6): 669 doi: 10.1007/s11604-022-01384-w
|
| 9 |
Bryan Cho Wing Li, Joanne Chiu, Kit Shing, Gerry Gin Wai Kwok, Vikki Tang, Roland Leung, Ka Wing Ma, Wong Hoi She, Josephine Tsang, Albert Chan, Tan To Cheung, Chung Mau Lo, Thomas Yau. The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants. Advances in Therapy 2021; 38(7): 3900 doi: 10.1007/s12325-021-01800-z
|
| 10 |
Maria J Citores, Jose L Lucena, Sara de la Fuente, Valentin Cuervas-Mons. Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation. World Journal of Hepatology 2019; 11(1): 50-64 doi: 10.4254/wjh.v11.i1.50
|
| 11 |
Vasiliy I. Reshetnyak, Igor V. Maev, Tatiana M. Reshetnyak, Sergei V. Zhuravel, Vladimir M. Pisarev. Liver Disease and Hemostasis (Review) Part 2. Cholestatic Liver Disease and Hemostasis. General Reanimatology 2019; 15(6): 80 doi: 10.15360/1813-9779-2019-6-80-93
|
| 12 |
Wong Hoi She, Miu Yee Chan, Ka Wing Ma, Simon H. Y. Tsang, Wing Chiu Dai, Albert C. Y. Chan, Chung Mau Lo, Tan To Cheung. Alpha-Fetoprotein in Predicting Survival of Patients with Ruptured Hepatocellular Carcinoma after Resection. Journal of Investigative Surgery 2022; 35(5): 1091 doi: 10.1080/08941939.2021.2012615
|
| 13 |
Beshoy Effat Elkomos, Mostafa Abdo, Remon Mamdouh, Amr Abdelaal. Can living donor liver transplantation provide similar outcomes to deceased-donor liver transplantation for hepatocellular carcinoma? A systematic review and meta-analysis. Hepatology International 2023; 17(1): 18 doi: 10.1007/s12072-022-10435-3
|
| 14 |
Yan-Ping Yu, Allan Tsung, Silvia Liu, Michael Nalesnick, David Geller, George Michalopoulos, Jian-Hua Luo. Detection of fusion transcripts in the serum samples of patients with hepatocellular carcinoma. Oncotarget 2019; 10(36): 3352 doi: 10.18632/oncotarget.26918
|
| 15 |
Chunling Wang, Xiaozhun Huang, Xiaofeng Lan, Dongmei Lan, Zhangkan Huang, Shu Ye, Yihong Ran, Xinyu Bi, Jianguo Zhou, Xu Che. Research progress of spontaneous ruptured hepatocellular carcinoma: Systematic review and meta-analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.973857
|
| 16 |
Yajuan Sun, Can Yu, Xinxin Wang, Rui Yang, ZhiPeng Ding, Yang Zhou. Establishment and Validation of the LI-RADS Morphologic Type II Hepatocellular Carcinoma Early Recurrence Risk Scoring System. Journal of Gastrointestinal Surgery 2023; 27(12): 2787 doi: 10.1007/s11605-023-05873-9
|
| 17 |
Arno Kornberg, Martina Schernhammer, Jennifer Kornberg, Helmut Friess, Katharina Thrum. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma. Digestive Diseases and Sciences 2019; 64(1): 269 doi: 10.1007/s10620-018-5296-9
|
| 18 |
Andreas A. Schnitzbauer, Natalie Filmann, René Adam, Philippe Bachellier, Wolf O. Bechstein, Thomas Becker, Sherrie Bhoori, Itxarone Bilbao, Jens Brockmann, Patrizia Burra, Olivier Chazoullières, Umberto Cillo, Michele Colledan, Christoph Duvoux, Tom M. Ganten, Jean Gugenheim, Michael Heise, Bart van Hoek, Neville Jamieson, Koert P. de Jong, Christian G. Klein, Jürgen Klempnauer, Norman Kneteman, Jan Lerut, Heikki Mäkisalo, Vincenzo Mazzaferro, Darius F. Mirza, Silvio Nadalin, Peter Neuhaus, George-Philippe Pageaux, Antonio D. Pinna, Jaques Pirenne, Johann Pratschke, James Powel, Markus Rentsch, Magnus Rizell, Giorgio Rossi, Lionel Rostaing, André Roy, Tim Scholz, Utz Settmacher, Thomas Soliman, Simone Strasser, Gunnar Söderdahl, Roberto I. Troisi, Victor Sánchez Turrión, Hans J. Schlitt, Edward K. Geissler. mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors. Annals of Surgery 2020; 272(5): 855 doi: 10.1097/SLA.0000000000004280
|
| 19 |
Paulo Henrique Lima, Boyan Fan, Joshua Bérubé, Milena Cerny, Damien Olivié, Jeanne-Marie Giard, Catherine Beauchemin, An Tang. Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma. American Journal of Roentgenology 2019; 213(1): 17 doi: 10.2214/AJR.18.20341
|